Philip Van Damme

Citat de

	Toate	Din 2020
Referințe bibliografice	34876	22462
h-index	96	71
i10-index	343	309

6000

3000

1500

4500

20062007200820092010201120122013201420152016201720182019202020212022202320242025117 205 222 268 384 485 625 751 875 971 1123 1483 1904 2410 3094 3940 4382 4744 5203 1051

Acces public

Afișați-le pe toate

340 de articole

33 de articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Ludo Van Den BoschKU Leuven & VIBAdresă de e-mail confirmată pe kuleuven.vib.be
Koen Poesenprofessor, University of Leuven, KU Leuven, BelgiumAdresă de e-mail confirmată pe uzleuven.be
Orla HardimanTrinity College DublinAdresă de e-mail confirmată pe hardiman.net
Rik VandenbergheUniversity of LeuvenAdresă de e-mail confirmată pe uz.kuleuven.ac.be
Adriano Chio'Professor of Neurology, 'Rita Levi Montalcini' Department of Neuroscience, University of TurinAdresă de e-mail confirmată pe unito.it
Dietmar ThalProfessor for NeuropathologyAdresă de e-mail confirmată pe kuleuven.be
Koen Van Laere, MD PhD DrScHoogleraar KU LeuvenAdresă de e-mail confirmată pe telenet.be
ammar al-chalabiProfessor of Neurology and Complex Disease Genetics, King's College LondonAdresă de e-mail confirmată pe kcl.ac.uk
robin lemmensUZ leuven, KU LeuvenAdresă de e-mail confirmată pe vib-kuleuven.be
Peter De JongheVIB Department of Molecular Genetics, Neurogenetics Group, University of Antwerp, Institute BornAdresă de e-mail confirmată pe molgen.vib-ua.be
Kristel SleegersVIB-Department of Molecular Genetics - University of AntwerpAdresă de e-mail confirmată pe molgen.vib-ua.be
Louis De MuynckAdresă de e-mail confirmată pe its.jnj.com
Mamede de CarvalhoFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, PortugalAdresă de e-mail confirmată pe fm.ul.pt
Peter Carmeliethoogleraar, Universiteit van Leuven, VIBAdresă de e-mail confirmată pe kuleuven.vib.be
Maarten SchrootenDienst Neurologie, UZ LeuvenAdresă de e-mail confirmată pe uzleuven.be
Kim A. StaatsDirector of Rare Disease Drug Development, INmune BioAdresă de e-mail confirmată pe inmunebio.com
Susanne PetriProfessorin für Neurologie, Medizinische Hochschule HannoverAdresă de e-mail confirmată pe mh-hannover.de
Sharon AbrahamsUniversity of EdinburghAdresă de e-mail confirmată pe ed.ac.uk
Diether LambrechtsLaboratory for Translational Genetics, Department of Oncology, VIB and KULeuven, Leuven, BelgiumAdresă de e-mail confirmată pe vib-kuleuven.be
Steven BoeynaemsAssistant Professor, Baylor College of MedicineAdresă de e-mail confirmată pe bcm.edu

Urmăriți

Philip Van Damme

Professor of Neuroscience, University of Leuven

Adresă de e-mail confirmată pe uzleuven.be

ALS FTD progranulin C9orf72 TDP-43


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis: European journal of neurology 19 (3), 360-375, 2012	1158	2012
Amyotrophic lateral sclerosis: a clinical review P Masrori, P Van Damme European journal of neurology 27 (10), 1918-1929, 2020	1016	2020
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019	867	2019
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017	693	2017
Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018	666	2018
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016	633	2016
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis L Van Den Bosch, P Van Damme, E Bogaert, W Robberecht Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (11-12 …, 2006	627	2006
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS E Storkebaum, D Lambrechts, M Dewerchin, MP Moreno-Murciano, ... Nature neuroscience 8 (1), 85-92, 2005	622	2005
Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs J Jiang, Q Zhu, TF Gendron, S Saberi, M McAlonis-Downes, A Seelman, ... Neuron 90 (3), 535-550, 2016	620	2016
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ... New England Journal of Medicine 387 (12), 1099-1110, 2022	593	2022
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease C d'Ydewalle, J Krishnan, DM Chiheb, P Van Damme, J Irobi, ... Nature medicine 17 (8), 968-974, 2011	586	2011
Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics S Boeynaems, E Bogaert, D Kovacs, A Konijnenberg, E Timmerman, ... Molecular cell 65 (6), 1044-1055. e5, 2017	553	2017
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ... New England Journal of Medicine 383 (2), 109-119, 2020	541	2020
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018	508	2018
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival P Van Damme, A Van Hoecke, D Lambrechts, P Vanacker, E Bogaert, ... The Journal of cell biology 181 (1), 37-41, 2008	487	2008
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021	401	2021
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients W Guo, M Naujock, L Fumagalli, T Vandoorne, P Baatsen, R Boon, ... Nature communications 8 (1), 861, 2017	387	2017
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans A Van Hoecke, L Schoonaert, R Lemmens, M Timmers, KA Staats, ... Nature medicine 18 (9), 1418-1422, 2012	365	2012
Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018	354	2018
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter I Gijselinck, S Van Mossevelde, J van der Zee, A Sieben, S Engelborghs, ... Molecular psychiatry 21 (8), 1112-1124, 2016	313	2016

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori